These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7612033)

  • 1. End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency.
    Hilsden RJ; Urbanski SJ; Swain MG
    Arthritis Rheum; 1995 Jul; 38(7):1014-8. PubMed ID: 7612033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR; Millward-Sadler GH; Barbatis C; Wright R
    N Engl J Med; 1981 Mar; 304(10):557-60. PubMed ID: 6969850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tempting liver fibrosis? Long-term psoriatic methotrexate therapy and heterozygous alpha1-antitrypsin deficiency.
    Mathew J; Igbokwe UO; Morley N; Burt AD
    Dermatology; 2006; 213(2):147-9. PubMed ID: 16902293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults.
    Vecchio FM; Fabiano A; Orsini G; Ragusa D; Massi G
    Digestion; 1983; 27(2):100-4. PubMed ID: 6354808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
    Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
    Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
    Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
    Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin deficiency: rare cause of adult cirrhosis--a case report.
    Tucker LE; Rawson PG
    Mo Med; 1993 Jan; 90(1):27-30. PubMed ID: 8421451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.
    Walker AM; Funch D; Dreyer NA; Tolman KG; Kremer JM; Alarcón GS; Lee RG; Weinblatt ME
    Arthritis Rheum; 1993 Mar; 36(3):329-35. PubMed ID: 8452577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-antitrypsin protease inhibitor SZ phenotype and liver cirrhosis.
    Coli A; Bigotti G
    Appl Pathol; 1989; 7(1):54-60. PubMed ID: 2784975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-1-antitrypsin deficiency--a cause of cryptogenic liver disease in the elderly.
    Battle WM; Matarazzo SA; Selhat GF; Catalano E
    J Clin Gastroenterol; 1982 Jun; 4(3):269-73. PubMed ID: 6980239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH; Cooney PT; Kerlin P
    Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emphysema, cirrhosis, and heart block in a young patient with partial alpha 1 antitrypsin deficiency (PiMZ phenotype).
    McDonald CF; Stewart PM; Blundell G; Crompton GK
    Br Med J (Clin Res Ed); 1985 Dec; 291(6510):1673-4. PubMed ID: 3935236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease and heterozygous alpha-1-antitrypsin deficiency.
    Pittschieler K
    Acta Paediatr Scand; 1991 Mar; 80(3):323-7. PubMed ID: 2035327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.